Tarang Sharma is an Endocrinology/Metabolic physician. OpenAlex indexes 59 publications with 1,314 citations (h-index 18).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
625 Africa Rd Ste 200
Westerville, OH 43082
Telephone
614-891-8080Provider last certified this registry record 14 Apr 2021.
Industry payments
54 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year202516 payments
- Medtronic, Inc.Program year20255 payments
- Novo Nordisk IncProgram year202513 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
75.9%Insulin Analog25.7%Tresiba Flextouch U-10013%Novolog Flexpen11%Basaglar Kwikpen U-10010%Toujeo Max Solostar9%Humalog Kwikpen U-2007%Tresiba Flextouch U-2007%Fiasp Flextouch6%Humalog Kwikpen U-1006%Lantus Solostar6%Humalog4%Insulin Lispro Kwikpen U-1004%Insulin Lispro4%Novolog4%Toujeo Solostar3%Lyumjev Kwikpen U-1003%Admelog Solostar2%Part D<11 patientsGLP-1 receptor agonist15%Ozempic58%Trulicity26%Mounjaro16%Part D<11 patients+ 7 more classes in this area
Hormonal (systemic)
15.7%l-Thyroxine10.7%Levothyroxine Sodium63%Synthroid31%Levoxyl6%Part D<11 patientsThyroid Hormone Synthesis Inhibitor2.4%Methimazole100%Part D≥17 patients+ 2 more classes in this area
Cardiovascular
5.9%Statin2.3%Atorvastatin Calcium67%Rosuvastatin Calcium33%Part D<11 patientsACE inhibitor2%Lisinopril100%Part D≥11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- National strategies for knowledge translation in health policy-making: A scoping review of grey literature
Health Research Policy and Systems
2024 - A MULTICENTRIC STUDY ON GENOMIC INSIGHTS OF ESBL PRODUCING ESCHERICHIA COLI CAUSING COMMUNITY-ACQUIRED URINARY TRACT INFECTION IN CHILDREN IN INDIA: PREDICTING NEAR FUTURE
International Journal of Infectious Diseases
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Bruce Bartholow Duncan
Universidade Federal do Rio Grande do Sul
Alireza Esteghamati
Tehran University of Medical Sciences
Paul Zimmet
Monash University
André Pascal Kengne
South African Medical Research Council
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”